Inventor

METCALF ANDREW T

US25 patents

⚠️ This page may combine multiple inventors who share the name “METCALF ANDREW T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

METCALF ANDREW T

ARRAY BIOPHARMA INC

2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

Crystalline forms

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Serine/threonine kinase inhibitors

Serine/threonine kinase inhibitors

Serine/threonine kinase inhibitors

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Bicyclic fused pyridine compounds as inhibitors of TAM kinases

Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors

2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases

Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors

Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibitors

Fused heterocyclic compounds as RET kinase inhibitors

LOXO ONCOLOGY INC

Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile

Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile

Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbontrile